Clevidipine

Results: 65



#Item
31_______________________ CONTRAINDICATIONS _______________________  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CARDENE IV.

_______________________ CONTRAINDICATIONS _______________________ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CARDENE IV.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-07-24 13:09:08
32Baxter Formatting Template

Baxter Formatting Template

Add to Reading List

Source URL: www.fda.gov.

Language: English
33	 Venous thrombotic events (VTE) have been observed, including fatal pulmonary emboli (PE). Monitor for signs and symptoms of VTE and PE. (5.6) 	 Gastrointestinal perforation or fistula has occurred. Fatal perforat

 Venous thrombotic events (VTE) have been observed, including fatal pulmonary emboli (PE). Monitor for signs and symptoms of VTE and PE. (5.6)  Gastrointestinal perforation or fistula has occurred. Fatal perforat

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-04-27 08:30:21
34RECENT MAJOR CHANGES Boxed Warnings Indications and Usage (1.1, 1.2) Dosage and Administration[removed]Contraindications (4) Warnings and Precautions (5.1, 5.5, 5.8, 5.10)

RECENT MAJOR CHANGES Boxed Warnings Indications and Usage (1.1, 1.2) Dosage and Administration[removed]Contraindications (4) Warnings and Precautions (5.1, 5.5, 5.8, 5.10)

Add to Reading List

Source URL: www.fda.gov

Language: English
35Sample Written Request for Oral Antihypertensives  Sample Written Request~:fwOraI _

Sample Written Request for Oral Antihypertensives Sample Written Request~:fwOraI _

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-09-25 04:40:56
36Alcohols / Atenolol / Metoprolol / Methadone / Adrenergic beta-antagonist / Clevidipine / Chemistry / Organic chemistry / Beta blockers

PPMC #[removed]Page 1 of[removed] –Pilot Physician’s Orders for Peri-Operative Beta Blockers Check appropriate box(es) where multiple order options occur & complete blank lines. All other orders are

Add to Reading List

Source URL: www.scoap.org

Language: English - Date: 2013-03-29 15:13:52
37HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYLVANT™ safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for Injection,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYLVANT™ safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for Injection,

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-23 16:33:01
381 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-22 13:43:13
39Cardene® I.V. Premixed Injection (0.1 mg/mL) in either 4.8% Dextrose or 0.86% Sodium Chloride Rx Only HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cardene I.V.

Cardene® I.V. Premixed Injection (0.1 mg/mL) in either 4.8% Dextrose or 0.86% Sodium Chloride Rx Only HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cardene I.V.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-01-20 12:05:19
40Desferal® deferoxamine mesylate for injection USP Vials Rx only Prescribing Information

Desferal® deferoxamine mesylate for injection USP Vials Rx only Prescribing Information

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-12-20 14:34:24